UNICREDIT BANK/CALL/PFIZER INC/30/0.1/18.09.24 | Market Closed - BOERSE MUENCHEN 15:41:32 2024-07-01 EDT | ||
| 0.059 EUR | +13.46% |
|
| Current month | +13.46% | ||
| 1 month | -35.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 0.059 | +13.46% |
| 24-06-28 | 0.052 | +4.00% |
| 24-06-27 | 0.05 | +8.70% |
| 24-06-26 | 0.046 | -16.36% |
| 24-06-25 | 0.055 | -1.79% |
Real-time BOERSE MUENCHEN
Last update July 01, 2024 at 03:41 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| WKN | HD0BDT |
| ISIN | DE000HD0BDT9 |
| Date issued | 2023-10-31 |
| Strike | 30 $ |
| Maturity | 2024-09-18 (79 Days) |
| Parity | 10 : 1 |
| Emission price | 0.35 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.37 € |
|---|---|
| Lowest since issue | 0.039 € |
| Spread | 0.005 € |
| Spread % | 8.20% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.22
USD
Average target price
31.92
USD
Spread / Average Target
+13.10%
- Stock Market
- Warrants
- Warrant
